江苏省某医院行机器人胃癌根治术的卫生经济学研究

doi:10.3969/j.issn.1006-5253.2023.03.007

Abstract
Figure/Table
References (0)
Related Citation (5)

Download: PDF (889 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract Objective To analyze the cost and postoperative rehabilitation of patients with gastric cancer undergoing robot-assisted therapy, and to evaluate the health economics of Da Vinci robot-assisted radical gastrectomy, traditional gastrectomy and laparoscopic-assisted radical gastrectomy in a hospital in Jiangsu Province.Methods One hundred and thirteen patients who underwent radical gastrectomy for gastric cancer in the general surgery department of Jiangsu Hospital of Traditional Chinese Medicine from July 1, 2020 to July 31, 2021 were selected as the study subjects, and were divided into 3 groups according to surgical methods: the robot-assisted laparoscopic radical gastrectomy for gastric cancer group (n=46), the traditional gastrectomy group (n=26), and the laparoscopic radical gastrectomy group (n=41). The cost, cost structure and postoperative rehabilitation indexes of the three groups of patients were compared and analyzed.Results 1) There were significant differences in the total cost, drug cost, especially Western medicine cost, surgical consumables cost, diagnosis and treatment service cost, and inspection cost between the robot group and the open surgery group and the laparoscopic group (P＜0.05). The decrease of drug cost in the robot group was the largest, and the difference was statistically significant (P<0.05) 2) In the robot group, the ventilation time (3.02±0.33)d, defecation time (4.00±0.29)d, first oral feeding time (1.80±0.36)d, catheter removal time (0.78±0.61)d and postoperative discharge days (5.72±0.70) were significantly advanced (P＜0.05). There was no significant difference in the incidence of postoperative complications (P＞0.05). 3) There was a statistically significant difference in out-of-pocket payment between the robot group and the traditional surgery group (P＜0.05).Conclusion Da Vinci robot-assisted radical gastrectomy significantly reduced the drug cost of patients, greatly reduced hospital stay and achieved rapid recovery, and was as safe and effective as traditional surgery and laparoscopic techniques. It is inevitable and necessary to implement Da Vinci robotic surgery under the background of the new medical reform, which could improve the quality of medical services and save medical and health resources.

Key words： Da Vinci robot gastric cancer enhanced recovery after surgery (ERAS) health economics

Received: 16 November 2022

PACS:

Fund:

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Zhang Xiaochun
	Shen Danli
	Gong Guanwen
	Jiang Zhiwei

Cite this article:

Zhang Xiaochun,Shen Danli,Gong Guanwen, et al. Health economics research on robotassisted radical gastrectomy for gastric cancer in a hospital in Jiangsu Province[J]. journal1, 2023, 30(3): 198-202.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2023.03.007 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2023/V30/I3/198

［1］LIU X X, PAN H F, JIANG Z W, et al. “fast-track” and “minimally invasive” surgery for gastric cancer［J］. Chin Med J (Engl), 2016, 129(19):2294-2300. DOI: 10.4103/0366-6999.190659.

［2］PLOUSSARD G, ALMERAS C, BEAUVAL J B, et al. A combination of enhanced recovery after surgery and prehabilitation pathways improves perioperative outcomes and costs for robotic radical prostatectomy［J］. Cancer, 2020, 126(18):4148-4155. DOI: 10.1002/cncr.33061.

［3］阚明韵,柳欣欣,江志伟.机器人胃癌根治术的现状与展望［J］.机器人外科学杂志(中英文),2022,3(4):337-342.

［4］SUN L F, LIU K, SU X S, et al. Robot-assisted versus laparoscopic-assisted gastrectomy among gastric cancer patients: A retrospective short-term analysis from a single institution in China［J］. Gastroenterol Res Pract, 2019, 2019:9059176. DOI: 10.1155/2019/9059176.

［5］CHEN J W, ZHANG Z Y, CHANG W J, et al. Short-term and long-term outcomes in mid and low rectal cancer with robotic surgery［J］.Front Oncol,2021,11:603073.DOI:10.3389/fonc.2021.603073.

［6］LU J, ZHENG C H, XU B B, et al. Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: A randomized controlled trial［J］.Ann Surg,2021,273(5):858-867.DOI:10.1097/SLA.0000000000004466.

［7］薛满,夏鹏,常东民.快速康复医学在达芬奇机器人胃癌根治术中的应用［J］.现代肿瘤医学,2021,29(1):81-84.DOI: 10.3969/j.issn.1672-4992.2021.01.018.

［8］谢贤宇,吴勤德,李跃平,等.达芬奇机器人辅助低位直肠前切除术的卫生经济学评价［J］.包头医学院学报,2021,37(10):110-116.DOI: 10.16833/j.cnki.jbmc.2021.10.026.

［9］马爱平.国产手术机器人冲击“达芬奇”垄断地位［N］.科技日报,2021-10-13(8).

［10］何双双.达芬奇机器人辅助前列腺癌手术应用评价［J］.解放军医院管理杂志,2021,28(6):558-560.DOI: 10.16770/J.cnki.1008-9985.2021.06.021.

［11］GUERRINI G P, ESPOSITO G, MAGISTRI P, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: The largest meta-analysis［J］. Int J Surg, 2020, 82:210-228. DOI: 10.1016/j.ijsu.2020.07.053.

［12］SUDA K, MAN-I M, ISHIDA Y, et al. Potential advantages of robotic radical gastrectomy for gastric adenocarcinoma in comparison with conventional laparoscopic approach: A single institutional retrospective comparative cohort study［J］. Surg Endosc, 2015, 29(3):673-685. DOI: 10.1007/s00464-014-3718-0.

［13］姚世学.在DRGs付费方式下公立医院绩效考核与分配的探索［J］.财会学习,2022(7):135-137.DOI: 10.3969/j.issn.1673-4734.2022.07.046.